Acute lethality and stress-responsive phenotypes differ among three Acinetobacter baumannii strains: phenotypic, genomic and transcriptomic analyses

In the world of infectious disease, not all bacteria of the same species are created equal. Imagine a crowd of people who all share the same last name; while they might look similar from a distance, their personalities, strengths, and weaknesses can be vastly different. This is true for Acinetobacter baumannii, a bacterium that has become a major concern in hospitals worldwide. It is an opportunistic pathogen, meaning it waits for a chance to strike, often attacking patients who are already weak, such as those on ventilators or with open wounds. What makes this bacterium particularly dangerous is its ability to resist many common antibiotics, earning it a reputation as a "superbug." Scientists have long known that different strains of this bacterium behave differently in the lab, but the rules governing these differences have remained unclear. Does a strain that is deadly in a mouse also make the best biofilm? Does a strain that grows fast in a petri dish also survive the best in human blood? Understanding these connections is vital because it helps doctors predict how a specific infection might behave and how best to treat it.

A team of researchers set out to solve this puzzle by comparing three distinct strains of Acinetobacter baumannii that had very different histories. One strain, known as LS01, was isolated from a patient with a severe lung infection and is generally susceptible to antibiotics. Another, AB5075, is a well-known, highly resistant strain often used by scientists as a standard reference for studying how the bacteria cause disease. The third, XH386, was found in a child with pneumonia and carries multiple drug-resistance genes. The researchers wanted to see if these genetic differences translated into clear patterns of behavior. They put the bacteria through a series of rigorous tests, watching how they grew, how they survived in living creatures, how they clung to human cells, and how they reacted to stressors like human blood serum and low doses of antibiotics.

The results revealed a surprising lack of a single "super-strain." Instead, each bacterium excelled in different areas, proving that being deadly in one context does not guarantee dominance in another. When the researchers injected the bacteria into wax moth larvae, a common model for testing infection, the LS01 strain proved to be the most lethal, killing the majority of the larvae within four days. This pattern held true when the team moved to mice. When the bacteria were introduced into the lungs of mice at a specific dose, the LS01 strain killed 25% of the animals within five days. In stark contrast, the mice infected with the other two strains, AB5075 and XH386, all survived the same challenge. This was a significant finding because it showed that the strain often used as a "highly virulent" reference in labs did not necessarily kill mice under these specific conditions, while a strain from a real patient did.

However, the story changed when the researchers looked at how the bacteria interacted with human cells and surfaces. While LS01 was the most deadly to the living hosts, the XH386 strain was the champion of attachment. When placed on human lung cells in a dish, XH386 clung to the surface more effectively than the other two strains in repeated experiments. It also formed the strongest biofilms—slime-like communities of bacteria—when exposed to heat-treated human blood serum. This suggests that XH386 is exceptionally good at sticking to surfaces and building protective communities, even if it is less immediately lethal to the whole organism than LS01. Meanwhile, the AB5075 strain displayed the most visible protective coating, or capsule, around its body when viewed under a powerful electron microscope, yet this did not make it the most lethal or the best at sticking to cells.

The researchers also investigated how the bacteria reacted to stress, such as the presence of human blood serum or low levels of the antibiotic colistin. They found that the bacteria's responses were highly specific to the strain and the environment. For instance, when the XH386 strain was starved of iron, a nutrient it needs to survive inside a host, it switched on a massive number of genes to find and capture iron. This reaction was much stronger than its response to the antibiotic or the blood serum. Interestingly, the genes that controlled the bacteria's ability to resist antibiotics were clearly different between the strains, matching what the researchers saw in the lab. The resistant strains carried specific genetic tools to fight drugs, while the susceptible strain did not. Yet, the genes responsible for causing disease, like those for making biofilms or capturing iron, were present in all three strains.

This leads to the core conclusion of the study: having the same genetic toolkit does not mean the bacteria will act the same way. The three strains shared most of the major genes needed to cause disease and survive stress, yet they behaved very differently. The differences were not due to one strain having a gene that the others lacked, but rather how each strain used the genes it already had. The LS01 strain was a potent killer in the living host, the XH386 strain was a master of attachment and biofilm formation, and the AB5075 strain had a thick protective coat but showed intermediate lethality. The study demonstrates that you cannot predict how dangerous a specific strain of Acinetobacter baumannii will be just by looking at its genetic list or assuming that resistance to drugs means it will be more deadly. Instead, the behavior of these bacteria is a complex mix of their genetic potential and how they choose to use it in response to their environment.